Sep 30, 2014

United Therapeutics Q3 2014 Earnings Report

Total Revenue
$330M
Previous year: $302M
+9.2%
EPS
$3.91
Previous year: $2.98
+31.2%
Gross Profit
$289M
Previous year: $272M
+6.5%
Cash and Equivalents
$497M
Previous year: $322M
+54.3%
Total Assets
$2.07B
Previous year: $1.93B
+7.5%

United Therapeutics

United Therapeutics